These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ebid AH; Ahmed MM; Mohammed SA Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887 [TBL] [Abstract][Full Text] [Related]
29. Individualization of anticonvulsant therapy. Atkinson AJ Med Clin North Am; 1974 Sep; 58(5):1037-49. PubMed ID: 4609361 [No Abstract] [Full Text] [Related]
30. Interaction between phenytoin and valproate. Sansom LN; Beran RC; Schapel GJ Med J Aust; 1980 Aug; 2(4):212. PubMed ID: 6776391 [TBL] [Abstract][Full Text] [Related]
31. Inadequate serum levels after intramuscular administration of diphenylhydantoin. Wilensky AJ; Lowden JA Neurology; 1973 Mar; 23(3):318-24. PubMed ID: 4735182 [No Abstract] [Full Text] [Related]
33. The role of antiepileptic blood levels in the treatment of patients with epilepsy. Fincham RW; Schottelius DD J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131 [No Abstract] [Full Text] [Related]
34. [Diphenylhydantoin poisoning induced by isoniazide. A further case]. Beauvais P; Mercier D; Hanoteau J; Brissaud HE Arch Fr Pediatr; 1973 May; 30(5):541-6. PubMed ID: 4733654 [No Abstract] [Full Text] [Related]
35. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study]. Hernández R; Fernández Mde L; Miranda G; Suástegui R Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636 [TBL] [Abstract][Full Text] [Related]
36. [Critical remarks about the monitoring of antiepileptic drug levels in pediatric age (author's transl)]. Gaggero R; La Medica ; De Negri M Pediatr Med Chir; 1981; 3(2-3):151-8. PubMed ID: 6806780 [TBL] [Abstract][Full Text] [Related]
37. [Oral loading dose of phenytoin]. Galdames D; Aguilera L; Castillo S; Valenzuela M; Leyton S; Saavedra IN Rev Med Chil; 1988 Nov; 116(11):1162-6. PubMed ID: 3077203 [No Abstract] [Full Text] [Related]
38. [Methods of individualizing phenytoin dosage]. Ackerman Z; Shalev RZ; Zylber-Katz E; Levy M Harefuah; 1985 Nov; 109(10):274-6. PubMed ID: 4093042 [No Abstract] [Full Text] [Related]
39. Kinetics of intravenous phenytoin in children. Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185 [TBL] [Abstract][Full Text] [Related]
40. [Effectiveness of anticonvulsant monotherapy with phenytoin in relation to its plasma levels]. Martínez P; Sinués B; Chueca P; Mateo M; Larrosa A Arch Farmacol Toxicol; 1982 Dec; 8(3):231-6. PubMed ID: 7183258 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]